2020 Virtual AHA Scientific Sessions
On November 13, 2020, Resverlogix presented an oral presentation entititled: "BET Protein Inhibitor Apabetalone Suppresses Inflammatory Hyperactivation of Monocytes from Patients with Cardiovascular Disease and Type 2 Diabetes", as well as two poster presentations at the 2020 American Heart Association (AHA) Scientific Sessions virtual experience.
Copies of all three presentations can be accessed HERE.